<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-88 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-88</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-88</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <p><strong>Paper ID:</strong> paper-28d5642f18ca2981b504dc94a66d180bcb3fbad4</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/28d5642f18ca2981b504dc94a66d180bcb3fbad4" target="_blank">Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.</a></p>
                <p><strong>Paper Venue:</strong> Mayo Clinic proceedings</p>
                <p><strong>Paper TL;DR:</strong> The introduction of angiogenesis, epidermal growth factor receptor inhibitors, and other new anti-cancer agents is changing the present and future of this disease and will certainly increase the number of lung cancer survivors.</p>
                <p><strong>Cost:</strong> 0.028</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e88.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e88.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>TP53_germline</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Germline TP53 sequence variations</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Heritable TP53 mutations/family variants reported to increase lung cancer risk, with a strong multiplicative effect with cigarette smoking (carriers who smoked had markedly higher risk than non-smoking carriers).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>family study / observational genetic study</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Germline TP53 mutation carriers reported in pedigree/family-based analyses (paper cites increased risk among carriers who smoke versus carriers who do not); specific sample sizes not provided in text.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not detailed in this paper beyond smoking vs non-smoking status for carriers; intensity/dose not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Lung cancer occurrence in germline TP53 mutation carriers (ascertainment implied via clinical/family records as reported in cited study).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'TP53', 'variant_identifier': None, 'direction_of_effect': 'increased risk', 'association_in_smokers_or_via_smoking_intensity': 'Effect reported specifically stronger in carriers who smoke (carriers who smoked >3x likelihood of developing lung cancer than carriers who did not smoke).'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[{'genes': ['TP53'], 'environmental_factor': 'cigarette smoking (smoker vs non-smoker)', 'interaction_model': 'reported multiplicative effect (carrier smokers >> carrier non-smokers); exact model not quantified in paper', 'summary': 'Germline TP53 mutation carriers who smoked cigarettes were reported to be more than 3 times more likely to develop lung cancer than carriers who did not smoke.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Carriers who smoked cigarettes are reported to be more than 3 times more likely to develop lung cancer than carriers who did not smoke (from cited family study).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Inherited TP53 defects increase baseline susceptibility to carcinogenesis; cigarette smoking provides mutagenic exposure that greatly increases penetrance in carriers.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Paper reports the finding from prior family-based work; details on sample size, adjustment for other exposures, and quantitative interaction modeling are not provided in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e88.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_germline_T790M</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Germline EGFR T790M sequence variation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A germline EGFR T790M variant reported in a family with multiple NSCLC cases, suggesting rare inherited EGFR variants can predispose to lung cancer in families.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>family case report / pedigree study</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Single family with multiple NSCLC cases described in the literature; specific ancestry/size not detailed in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not specified in review for affected family members.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Familial clustering of NSCLC cases (clinical diagnosis/pathology in pedigree).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'EGFR', 'variant_identifier': 'T790M (germline, as reported)', 'direction_of_effect': 'predisposing / increased familial risk', 'association_in_smokers_or_via_smoking_intensity': 'Reported in a familial cluster; smoking status influence not detailed in review.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Rare germline activating EGFR variants may directly predispose to NSCLC through altered receptor signaling.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Based on a family report; rarity and generalizability to sporadic smoker risk not established in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e88.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>6q23-25_locus</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Susceptibility locus at chromosome 6p23-25</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A genome-wide linkage study reported a major lung cancer susceptibility locus mapping to chromosome 6p23-25 in extended families, indicating a heritable susceptibility region.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>genome-wide linkage in extended families</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Study of 52 extended families (included lung, laryngeal, throat cancers); details in cited study rather than this review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not detailed in this review; families likely included mixture of smoking statuses.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Familial lung cancer aggregation mapped to a chromosomal region (linkage-based ascertainment).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': None, 'variant_identifier': '6q23-25 locus (linkage region)', 'direction_of_effect': 'predisposing locus identified by linkage', 'association_in_smokers_or_via_smoking_intensity': 'Identified as a familial susceptibility locus; interaction with smoking not specified in review.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Linkage signal identified at chromosome 6p23-25 in a genome-wide linkage study of 52 families (reported as a 'major susceptibility locus').</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Unknown gene(s) within the linkage region may increase inherited susceptibility; mechanism not defined in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Linkage regions are broad and require fine mapping; review does not provide replication or effect-size estimates for population risk.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e88.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>15q25_nicotinic_locus</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Chromosome 15q25 region (CHRNA5-CHRNA3-CHRNB4 nicotinic acetylcholine receptor genes)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Three independent genetic studies identified a marker on chromosome 15q25 associated with increased lung cancer risk (~30% for one copy, 70–80% for two copies); region contains nicotinic receptor subunit genes that may influence nicotine dependence and thus exposure.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>genetic association / GWAS-like studies (three independent studies cited)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Three independent studies (details not provided in review) reported the association; review does not specify ancestral breakdown in text.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not fully detailed in review; review notes one investigator hypothesizes locus acts via increased nicotine addiction (i.e., higher exposure).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Lung cancer risk associated with genotype (case-control / association design in cited studies).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'CHRNA5-CHRNA3-CHRNB4 region', 'variant_identifier': None, 'direction_of_effect': 'increased risk; dose-dependent by allele count', 'association_in_smokers_or_via_smoking_intensity': 'Association could reflect direct genetic effect or indirect effect via increased nicotine dependence/exposure; review highlights both possibilities.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[{'genes': ['CHRNA5-CHRNA3-CHRNB4'], 'environmental_factor': 'cigarette smoking (dose/exposure mediated via nicotine dependence)', 'interaction_model': 'not explicitly modeled in review; suggested mediation/interaction via higher nicotine dependence leading to greater exposure', 'summary': 'Authors note the region contains nicotinic receptor genes; one interpretation is genes increase cancer risk by increasing vulnerability to nicotine addiction (thereby increasing smoking dose).'}]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>['Nicotine dependence (genetically influenced) — discussed as a pathway by which this locus may alter effective carcinogen dose.']</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Reported risk ~30% higher for people with 1 copy of the marker and ~70–80% higher for people with 2 copies (as reported across the three studies summarized in this review).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Variant(s) in nicotinic receptor genes may increase susceptibility either directly (biologic receptor-mediated carcinogenesis) or indirectly by increasing nicotine dependence and therefore cumulative tobacco carcinogen dose.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Review notes alternative explanations (direct oncogenic role vs exposure-mediated effect) and does not present causal mediation analyses; ancestry-specific effects and replication details are not provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e88.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR_somatic_mutations</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Somatic activating mutations in the EGFR tyrosine kinase domain (exon 19 deletions, L858R, L861Q, etc.)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Somatic EGFR mutations are strongly associated with sensitivity to EGFR tyrosine kinase inhibitors and are enriched in clinical subgroups (females, never-smokers, adenocarcinoma histology, and Asian descent), demonstrating tumor molecular heterogeneity by smoking status.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>somatic mutation association studies / translational molecular studies</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Tumor samples from NSCLC patients across multiple studies; review summarizes associations with clinical subgroups (never-smokers, Asians, females, adenocarcinoma).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Smoking status (never-smoker vs smoker) used to stratify association with somatic EGFR mutations; intensity not specified.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Tumor genotype (presence/absence of activating EGFR mutations) and clinical response to EGFR inhibitors; ascertainment by molecular sequencing of tumor tissue.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'EGFR (somatic)', 'variant_identifier': 'common types: exon 19 in-frame deletions (delE746-A750, delL747-T751insS, delL747-P753insS), exon 21 L858R, L861Q', 'direction_of_effect': 'activating mutations associated with sensitivity to EGFR inhibitors; enriched in never-smokers', 'association_in_smokers_or_via_smoking_intensity': 'Mutations are more common in tumors from never-smokers; hence their presence differs by smoking status and partly explains differential treatment response and possibly different pathways to carcinogenesis.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>['Somatic activating EGFR mutations (tumor DNA) described as a molecular marker that stratifies tumors by smoking history and predicts drug sensitivity.']</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>['EGFR activating mutations are more frequent in never-smokers; EGFR amplification prevalence differs by population (more common in Western populations), HER2 amplification more common in East Asian patients; these differences imply tumors arising in smokers vs never-smokers follow different molecular pathways.']</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>No numeric effect on incidence among smokers reported in review; review reports enrichment of EGFR mutations in never-smokers and association of these mutations with clinical response to EGFR inhibitors.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Distinct molecular pathways (EGFR-driven tumors) underlie cancers in subgroups (never-smokers, Asians), explaining heterogeneity in who develops certain tumor types and who responds to targeted therapy.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Findings pertain to tumor genotype (somatic) rather than inherited susceptibility; smoking measurement typically binary (never vs ever) in cited analyses.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e88.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>DNA_repair_genes</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>DNA repair pathway genes (ERCC1, ERCC2/XPD, XRCC1, RAD50, RAD51, RAD52, DNA-PK)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Variants and expression levels in DNA repair genes are discussed as influencing treatment response and plausibly affecting susceptibility by altering the ability to repair tobacco-induced DNA damage.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>candidate gene association / pharmacogenomics and mechanistic discussion</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Patients with NSCLC evaluated in clinical studies for treatment outcome associations (specific cohorts cited elsewhere); review summarizes correlations between gene expression/polymorphisms and survival after platinum chemotherapy or radiotherapy.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not directly specified for susceptibility analyses in review; discussed in context of treatment response to DNA-damaging therapies.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Treatment outcome (survival) and radiosensitivity; tumor expression (ERCC1) and allelic variants associated with differential survival after platinum chemotherapy.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'ERCC1', 'variant_identifier': None, 'direction_of_effect': 'overexpression correlates with poor survival in gemcitabine-cisplatin treated patients', 'association_in_smokers_or_via_smoking_intensity': 'Reported in treated patients; association with baseline susceptibility among smokers not directly reported in review.'}, {'gene': 'ERCC2/XPD, XRCC1', 'variant_identifier': None, 'direction_of_effect': 'allelic variants significantly associated with survival times for patients treated with platinum-based chemotherapy', 'association_in_smokers_or_via_smoking_intensity': 'Reported in treated patient cohorts; not explicitly tied to smoking-stratified incidence in this review.'}, {'gene': 'RAD50, RAD51, RAD52, DNA-PK', 'variant_identifier': None, 'direction_of_effect': 'involvement in homologous recombination and NHEJ repair pathways; defects can increase radiation sensitivity', 'association_in_smokers_or_via_smoking_intensity': 'Mechanistic role in DNA repair; direct epidemiologic association with smoker susceptibility not provided here.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>['ERCC1 overexpression (tumor) — poor survival after platinum therapy', 'Allelic variants of ERCC1/ERCC2 and XRCC1 — associated with survival in platinum-treated NSCLC', 'RAD and NHEJ pathway components — mechanistic discussion linking repair defects to radiation sensitivity']</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>ERCC1 overexpression correlates with poor survival among gemcitabine-cisplatin--treated patients; allelic variants of ERCC1/ERCC2 are significantly associated with survival times in platinum-treated patients (no incidence OR/HR for smoker susceptibility provided).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Variation in DNA repair capacity could modulate susceptibility to tobacco carcinogens by altering the persistence of DNA damage and subsequent mutagenesis, and may explain interindividual differences in cancer development among smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Most findings discussed relate to treatment outcome rather than baseline cancer risk among smokers; direct prospective evidence linking germline DNA repair variants to smoker-specific incidence is not provided in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e88.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Glutathione_pathway</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Glutathione metabolic detoxification pathway</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The glutathione pathway is discussed as a determinant of detoxification/inactivation of platinum compounds and as a mechanism of inherited/acquired drug resistance; suggests role of metabolic detoxification pathways in modifying response and possibly susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>mechanistic / pharmacogenomic discussion</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Discussed in context of patients receiving platinum chemotherapy for NSCLC; not presented as a population-based susceptibility study in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not applicable in the review's discussion of glutathione pathway (context is chemotherapy detoxification).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Treatment outcome / resistance to platinum agents rather than incidence risk.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene': 'multiple genes in glutathione metabolic pathway (general)', 'variant_identifier': None, 'direction_of_effect': 'involvement in drug detoxification and resistance; rapid detoxification associated with adverse treatment outcome', 'association_in_smokers_or_via_smoking_intensity': 'Discussed in treatment context; not directly tied to smoker susceptibility to primary lung cancer in review.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Differences in detoxification enzyme activity (glutathione pathway) may alter internal effective dose of carcinogens or chemotherapy agents, thereby influencing cancer risk or treatment response.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Discussion in review pertains primarily to chemotherapy resistance; direct epidemiologic evidence linking glutathione pathway variation to smoker-specific lung cancer incidence is not provided here.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e88.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Passive_smoke</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Secondhand (passive) tobacco smoke exposure</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Exposure to environmental tobacco smoke is causally associated with lung cancer and can explain a small fraction of lung cancers; studies report relative risks in never-smokers living with smokers and larger risks for childhood passive exposure.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>pooled analyses / meta-analyses and prospective studies (summarized)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Never-smokers exposed to household smokers (meta-analyses) and prospective cohorts (EPIC) including former and never smokers; exact populations vary by cited study.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Household exposure to a smoker (living with a smoker), childhood passive smoking; metrics vary by study referenced (binary exposure, retrospective history).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer in never-smokers or former smokers with passive exposure; outcomes from cohort/meta-analyses and observational studies.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>['Household exposure to smokers, childhood exposure — social/household factors that increase carcinogen exposure independent of personal smoking']</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Meta-analyses reported relative risks in never-smokers living with a smoker ranging from ~1.14 to 5.20; a prospective study reported childhood passive smoking increased adult lung cancer risk by 3.6-fold; overall passive smoking estimated to explain ~1.6% of lung cancers (review cites these figures).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Passive tobacco smoke increases cumulative inhaled carcinogen dose, raising lung cancer risk in never-smokers and potentially contributing to interindividual variation among those with differing household exposure histories.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Heterogeneity across studies and potential recall bias in exposure assessment; magnitude of effect varies by study design and exposure definition.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e88.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Air_pollution_and_occupational</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Ambient air pollution and occupational carcinogen exposures (PAHs, asbestos, silica, uranium/radiation)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Chronic exposure to ambient air pollution (PAH-rich emissions) and occupational carcinogens (asbestos, silica, uranium) are discussed as contributors to lung cancer risk and possible modifiers/confounders of smoking-related risk.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>epidemiologic evidence / occupational exposure studies / biomarker studies (referenced)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Urban populations (European burden estimate), exposed workers (miners, asbestos/silica-exposed workers); specifics given in cited literature.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Cumulative exposure to ambient air pollution and occupational carcinogens; not specified as pack-year equivalents in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer attributable fraction estimates and occupational cohort excess risk (as summarized from literature).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>['PAH-related biomarkers referenced in biomarker studies of air pollution (review cites PAH compounds and biomarker studies but does not detail specific analytes in this text).']</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>['Occupational exposure histories and urban residence (air pollution) that can confound or add to cigarette-related carcinogen dose.']</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Proportion of lung cancers attributable to urban air pollution in Europe estimated at ~11% (as cited in the review); occupational exposures (asbestos, silica, uranium) known to increase lung cancer risk in exposed workers.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Chronic exposure to PAHs and other pollutants causes oxidative stress, inflammation, and DNA damage contributing to lung carcinogenesis; combined exposures with smoking increase cumulative carcinogen dose.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Attribution estimates depend on exposure assessment and background smoking prevalence; interactions with smoking intensity and genetic susceptibility require further study.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.9">
                <h3 class="extraction-instance">Extracted Data Instance 9 (e88.9)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Diet_exercise_alcohol</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Dietary factors, physical activity, and alcohol consumption</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Diet (fruits/vegetables, carotenoids), exercise, and alcohol intake are discussed as modifiers of lung cancer risk, with mixed evidence: some protective signals for certain micronutrients and exercise, ambiguous/ harmful effects for supplements and high-dose carotenoids, and slight risk increase with high alcohol intake.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>epidemiologic cohort studies, meta-analyses, pooled analyses (summarized)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>General population cohorts and pooled analyses referenced; not limited to smokers only though some analyses stratify by smoking status in cited literature.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Not standardized in review; studies vary and often adjust for smoking status or stratify by smoking.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer from cohort and pooled analyses; specific ascertainment varies by cited study.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>['Dietary intake (fruits, vegetables, specific carotenoids), use of high-dose supplements (potentially harmful), leisure-time physical activity (protective), and alcohol consumption (≥30 g/day associated with slight increase in risk).']</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Physical activity associated with a 13%–30% reduction in lung cancer risk in some studies; pooled analysis reported slight increase in lung cancer risk among people consuming ≥30 g/day of alcohol; passive/ supplement results ambiguous with some high-dose carotenoid supplements possibly harmful.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>['Some studies show ambiguous results for carotenoids; some high-dose supplement trials indicated possible harm; no association observed between total or specific types of fat and lung cancer risk regardless of smoking status.']</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Antioxidant micronutrients may reduce oxidative DNA damage from tobacco carcinogens; physical activity may lower risk via systemic effects; high-dose supplements may have pro-oxidant or adverse mitochondrial effects.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Heterogeneity across dietary studies, potential confounding by smoking intensity and other lifestyle factors; supplement trials may not generalize to dietary intake.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.10">
                <h3 class="extraction-instance">Extracted Data Instance 10 (e88.10)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Smoking_behavior_and_cessation</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Smoking behavior, nicotine dependence, and cessation</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Behavioral differences among smokers (intensity, duration, dependence, cessation) strongly influence cumulative carcinogen dose and thereby differential lung cancer risk; cessation reduces mortality and likely incidence risk over time.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>cohort analyses / discussion of behavioral determinants</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Large cohorts and clinical series referenced broadly; review notes changes in smoker prevalence and composition (former vs current smokers) in populations.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Smoking status (current/former/never), duration of abstinence (used for survival analyses), and implied measures of dependence/intensity mediated by genetic loci; explicit pack-year metrics not detailed in review text.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer and survival after diagnosis; cessation associated with improved survival (relative risk per 10 years abstinence reported for mortality).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[{'genes': ['CHRNA5-CHRNA3-CHRNB4 region (as discussed)'], 'environmental_factor': 'smoking behavior (nicotine dependence leading to higher exposure)', 'interaction_model': 'mediation/indirect interaction proposed rather than explicitly modeled', 'summary': 'Genetic variants in nicotinic receptor genes may alter nicotine dependence and thus effective dose of tobacco carcinogens, explaining some interindividual differences in risk among smokers.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>['Cessation status and duration of abstinence (longer abstinence associated with reduced mortality); degree of nicotine dependence and smoking intensity (implied as mediators).']</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>In a study of patients with lung cancer, median survival for never smokers, former smokers, and current smokers was 1.4, 1.3, and 1.1 years respectively; relative risk per 10 years of smoking abstinence for mortality was 0.85 in female patients (survival context).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Differences in cumulative tobacco exposure (dose, duration, dependence) determine internal carcinogen dose and thus cancer risk; genetic loci affecting addiction may therefore indirectly influence risk.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Smoking exposure often measured crudely (current/former/never) in many referenced studies; pack-year and inhalation topography measures not consistently reported in review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e88.11">
                <h3 class="extraction-instance">Extracted Data Instance 11 (e88.11)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Tumor_molecular_divergence_by_smoking</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Tumor molecular features varying by smoking status (EGFR, HER2, EGFR amplification, response patterns)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review emphasizes that common tumors have different genetic backgrounds by population and smoking history (e.g., EGFR mutations enriched in never-smokers and Asians), which influences both risk patterns and therapeutic response.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>molecular epidemiology / tumor molecular profiling studies (summarized)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>NSCLC patient tumor series across populations (Western vs East Asian comparisons noted); subgroup descriptors include sex, smoking status, histologic subtype.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Smoking status (never vs ever) used to stratify mutation prevalence; detailed tobacco dose metrics not provided.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Tumor molecular phenotype (presence of somatic amplifications/mutations) and correlation with treatment response (EGFR-TKI sensitivity).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>['Somatic amplification (EGFR, HER2) and activating EGFR mutations as tumor molecular markers that differ by smoking history and population.']</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>['EGFR somatic activating mutations are more common in never-smokers and predict response to EGFR inhibitors; EGFR amplification more prevalent in Western populations; HER2 amplification more common in East Asian patients, highlighting biologic heterogeneity by smoking and ethnicity.']</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>No direct quantitative comparison of mutation prevalence between smokers and non-smokers provided numerically in review; qualitative enrichment is described.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Different etiologic pathways (e.g., EGFR-driven vs tobacco mutagen-driven tumors) produce different tumor genotypes, which helps explain why some individuals (e.g., never-smokers) develop lung cancer in the absence of heavy tobacco exposure, and why smokers may develop different molecular tumor types.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Mutation prevalence differences may be confounded by histology, sex, and ancestry; review summarizes primary literature without providing population-standardized prevalences.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.', 'publication_date_yy_mm': '2008-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk <em>(Rating: 2)</em></li>
                <li>A variant associated with nicotine dependence, lung cancer and peripheral arterial disease <em>(Rating: 2)</em></li>
                <li>A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 <em>(Rating: 2)</em></li>
                <li>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy <em>(Rating: 2)</em></li>
                <li>Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib <em>(Rating: 2)</em></li>
                <li>EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib <em>(Rating: 2)</em></li>
                <li>Air pollution and cancer: biomarker studies in human populations <em>(Rating: 2)</em></li>
                <li>The accumulated evidence on lung cancer and environmental tobacco smoke <em>(Rating: 1)</em></li>
                <li>Physical activity and cancer prevention—data from epidemiologic studies <em>(Rating: 1)</em></li>
                <li>Antioxidant vitamins and risk of lung cancer <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>